MRgART
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
University of Wisconsin, Madison
Overview
MRgART is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
MRgART clinical trials
Explore related
Medical disclaimer. This page summarizes research about MRgART for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.